Word: enovids
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...cycle. Analysis showed that the purified drug contained no detectable estrogen. Apparently estrogen, even in the most minute quantity, prevented some side effects, including unwanted bleeding. So when Chicago's G. D. Searle & Co., which had worked closely with Pincus and Rock, began making "the Pincus pills" as Enovid in 1957, the formulation contained 66 parts progestin to one part estrogen. The progestin dose has been reduced by as much as 90% in Searle's newest pills, Ovulen, but the combination principle is the same...
ACliffie in search of birth control pills will have heard various unconfirmed stories about the University Health Services. But the one that sticks in her mind is that doctors at the walk-in clinic dispense Enovid like Aspirin, and so she may find herself hopefully filling out a little card for the walk-in clinic at the brightly colored clinic entrance to 75 Mt. Auburn Street...
...Contrary to popular opinion, Prudence and the Pill was not written by Graham Blaine. It is a "bedroom farce" about what happens when a suspicious husband replaces his wife's Enovid with aspirin. Pregnancy is the obvious result, but when? And who? Written by Hugh Mills, published by Lippincott, and not worth the effort...
...injected. Now there is a plethora of estrogens and of the other sex hormones, progestins and androgens. Most of them are at least partly synthetic, and they can be taken easily by mouth. A couple of years ago, a patient who had kept on taking the birth-control pill Enovid after her menopause gave Dr. Wilson a new insight: the pill-which contains both a progestin and an estrogen-seemed adequate and acceptable for alleviating the "change of life...
...most dramatic new products to appear in recent years has been the oral contraceptive. First marketed five years ago, "the pill" is now made by seven U.S. companies under such trade names as Enovid (the first oral contraceptive, made by G. D. Searle & Co.), Norlestrin (Parke, Davis & Co.), and C-Quens (Eli Lilly & Co.). Sales of all oral contraceptives in the U.S., which were $46 million in 1964, rose to about $65 million in 1965 and are expected to hit $90 million this year...